Industries > Pharma > POC Diagnostics Market Forecast 2017-2027

POC Diagnostics Market Forecast 2017-2027

Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies

PUBLISHED: 12 September 2017
PAGES: 289
PRODUCT CODE: PHA0235

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

POC Diagnostics – our new study reveals trends, R&D progress, and predicted revenues
Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.

POC Diagnostics, by Product Type
• Blood Glucose
• Infectious Diseases
• Rapid Coagulation
• Rapid Cardiac Marker
• Cholesterol
• Pregnancy
• Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Switzerland
• Belgium
• The Netherlands
• Japan
• China
• India
• Brazil
• Russia
• South Africa
• RoW

POC Diagnostics Market Forecast 2017-2027

The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the POC Diagnostics Market report helps you
In summary, our 289-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 15 key national markets – See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 4 of the major companies involved in the POC Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today POC Diagnostic Systems Market Forecast 2017-2027: Analysis of POC Diagnostics Market Forecast 2017-2027: Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for POC Diagnostics Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for POC Diagnostics Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ